These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7841858)

  • 1. Opiate withdrawal.
    Farrell M
    Addiction; 1994 Nov; 89(11):1471-5. PubMed ID: 7841858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe opioid withdrawal syndrome after a single dose of nalmefene.
    Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
    Loimer N; Schmid RW; Presslich O; Lenz K
    J Psychiatr Res; 1989; 23(1):81-6. PubMed ID: 2547057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure.
    Pfab R; Hirtl C; Zilker T
    J Toxicol Clin Toxicol; 1999; 37(1):43-50. PubMed ID: 10078159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of opioid dependence within the South African context.
    Weich L
    SADJ; 2010 May; 65(4):168-71. PubMed ID: 20632700
    [No Abstract]   [Full Text] [Related]  

  • 7. Opiate detoxification protocols. A clinical manual.
    Fishbain DA; Rosomoff HL; Cutler R
    Ann Clin Psychiatry; 1993 Mar; 5(1):53-65. PubMed ID: 8394176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans.
    Stitzer ML; Wright C; Bigelow GE; June HL; Felch LJ
    Drug Alcohol Depend; 1991 Dec; 29(1):39-46. PubMed ID: 1665778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
    Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
    Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar efficacy of abrupt and gradual opiate detoxification.
    Loimer N; Linzmayer L; Schmid R; Grünberger J
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):307-12. PubMed ID: 1928024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology.
    Johnson RE; Fudala PJ; Jaffe JH
    NIDA Res Monogr; 1990; 105():585-6. PubMed ID: 1876130
    [No Abstract]   [Full Text] [Related]  

  • 13. Antagonist treatment of opioid withdrawal translational low dose approach.
    Mannelli P; Gottheil E; Van Bockstaele EJ
    J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The motivational component of withdrawal in opiate addiction: role of associative learning and aversive memory in opiate addiction from a behavioral, anatomical and functional perspective.
    Frenois F; Le Moine C; Cador M
    Rev Neurosci; 2005; 16(3):255-76. PubMed ID: 16323564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrashort withdrawal from opiate dependence].
    Scherbaum N; Kienbaum P
    Med Monatsschr Pharm; 2003 Aug; 26(8):278-82. PubMed ID: 12953381
    [No Abstract]   [Full Text] [Related]  

  • 17. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate withdrawal: the result of conditioning or physiological mechanisms?
    Zellner DA; Dacanay RJ; Riley AL
    Pharmacol Biochem Behav; 1984 Feb; 20(2):175-80. PubMed ID: 6538972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate detoxification under anaesthesia.
    Strang J; Bearn J; Gossop M
    BMJ; 1997 Nov; 315(7118):1249-50. PubMed ID: 9390045
    [No Abstract]   [Full Text] [Related]  

  • 20. Opioid dependence and cross-dependence in the isolated guinea-pig ileum.
    Schulz R; Seidl E; Wüster M; Herz A
    Eur J Pharmacol; 1982 Oct; 84(1-2):33-40. PubMed ID: 6291952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.